Volume 31, Issue 199 (8-2021)                   J Mazandaran Univ Med Sci 2021, 31(199): 156-161 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bahrami S, Tahmasebi-birgani M, Bijanzadeh M, Saberi A. PCSK9 Associated Promoter Methylation Status in Patients with Hyperlipidemia. J Mazandaran Univ Med Sci 2021; 31 (199) :156-161
URL: http://jmums.mazums.ac.ir/article-1-14469-en.html
Abstract:   (1090 Views)
 Background and purpose: Hyperlipidemia is one of the main risk factors for coronary artery disease and is defined as abnormal elevation of lipids or lipoproteins in the blood. Pcsk9 is the ninth member of the proprotein convertase family that binds to the LDLR on the surface of the hepatocyte, leading to degradation of LDLR in lysosomes which could cause hyperlipidemia. The present study aimed to analyze the methylation status of pcsk9 promoter in patients with hyperlipidemia.
Materials and methods: This case-control study was conducted in 50 patients with hyperlipidemia and 50 healthy controls. DNA isolation from whole blood was performed using salting out procedure. Promoter methylation of the Pcsk9 gene was analyzed by methylation-specific PCR (MSP). Ten MSP products were sequenced to confirm the data obtained.
Results: According to MSP results, methylation pattern of pcsk9 gene promoter displayed an unmethylated status among the patients and control individuals. In other words, no methylation was seen in case and control samples.
Conclusion: The current study showed no significant association between PCSK9 methylation pattern and blood lipid profile level in case group and control group.
Full-Text [PDF 300 kb]   (478 Downloads)    
Type of Study: Brief Report | Subject: genetic

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb